Renaissance Technologies’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-185,800
| Closed | -$868K | – | 3641 |
|
|
2024
Q4 | $868K | Buy |
185,800
+78,600
| +73% | +$367K | ﹤0.01% | 2573 |
|
|
2024
Q3 | $578K | Buy |
+107,200
| New | +$578K | ﹤0.01% | 2720 |
|
|
2023
Q3 | – | Sell |
-20,000
| Closed | -$182K | – | 3876 |
|
|
2023
Q2 | $182K | Sell |
20,000
-14,800
| -43% | -$135K | ﹤0.01% | 3325 |
|
|
2023
Q1 | $225K | Buy |
+34,800
| New | +$225K | ﹤0.01% | 3228 |
|
|
2022
Q3 | – | Sell |
-32,100
| Closed | -$284K | – | 4214 |
|
|
2022
Q2 | $284K | Buy |
+32,100
| New | +$284K | ﹤0.01% | 3482 |
|
|
2020
Q4 | – | Sell |
-40,000
| Closed | -$412K | – | 3541 |
|
|
2020
Q3 | $412K | Buy |
+40,000
| New | +$412K | ﹤0.01% | 2886 |
|